ImmunoGen shares are trading lower after the company reported Q2 financial results.
Portfolio Pulse from Benzinga Newsdesk
ImmunoGen shares are trading lower following the company's Q2 financial results announcement.
July 31, 2023 | 2:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ImmunoGen's stock price is trading lower after the company reported its Q2 financial results.
The company's Q2 financial results have not been well received by the market, leading to a decrease in the stock price. This is a direct impact on the company's stock and is likely to influence investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100